Skip to main content
HairCited

Platelet-rich plasma in the treatment of alopecia areata after COVID-19 vaccination.

Hsiang-Chiun Teng, Hsin-Hsu Chen
Case Report Clinical case reports 2023 8 次引用
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D37192849'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

研究类型
Case Reports
研究人群
None
持续时间
4 weeks
干预措施
Platelet-rich plasma in the treatment of alopecia areata after COVID-19 vaccination. None
对照组
None
主要结局
hair growth/density
效应方向
Neutral
偏倚风险
High

Abstract

KEY CLINICAL MESSAGE: Alopecia areata may develop in patients after COVID-19 vaccination. Platelet-rich plasma (PRP) has an outstanding anti-inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids. ABSTRACT: A 34-year-old female with no systemic illness presented with non-scarring hair loss after the second COVID-19 vaccination shot 4 weeks ago. The hair loss worsened and progressed to severe alopecia areata. We started double-spin PRP therapy. Her hair recovered completely after six courses of PRP treatment.

简要概述

Platelet‐rich plasma (PRP) has an outstanding anti‐inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids.

Used In Evidence Reviews

Similar Papers